| pubmed-article:10624433 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10624433 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:10624433 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
| pubmed-article:10624433 | lifeskim:mentions | umls-concept:C0015392 | lld:lifeskim |
| pubmed-article:10624433 | lifeskim:mentions | umls-concept:C0004057 | lld:lifeskim |
| pubmed-article:10624433 | lifeskim:mentions | umls-concept:C0751711 | lld:lifeskim |
| pubmed-article:10624433 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:10624433 | lifeskim:mentions | umls-concept:C0376249 | lld:lifeskim |
| pubmed-article:10624433 | lifeskim:mentions | umls-concept:C1314939 | lld:lifeskim |
| pubmed-article:10624433 | pubmed:dateCreated | 2000-1-14 | lld:pubmed |
| pubmed-article:10624433 | pubmed:abstractText | To retrospectively evaluate in patients with non-arteritic ischaemic optic neuropathy (NAION) whether aspirin reduces the frequency of second eye involvement. | lld:pubmed |
| pubmed-article:10624433 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10624433 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10624433 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10624433 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10624433 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10624433 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10624433 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10624433 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10624433 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:10624433 | pubmed:issn | 0950-222X | lld:pubmed |
| pubmed-article:10624433 | pubmed:author | pubmed-author:SteinbergD... | lld:pubmed |
| pubmed-article:10624433 | pubmed:author | pubmed-author:KurtzSS | lld:pubmed |
| pubmed-article:10624433 | pubmed:author | pubmed-author:SeligsohnUU | lld:pubmed |
| pubmed-article:10624433 | pubmed:author | pubmed-author:SalomonOO | lld:pubmed |
| pubmed-article:10624433 | pubmed:author | pubmed-author:Huna-BaronRR | lld:pubmed |
| pubmed-article:10624433 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10624433 | pubmed:volume | 13 ( Pt 3a) | lld:pubmed |
| pubmed-article:10624433 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10624433 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10624433 | pubmed:pagination | 357-9 | lld:pubmed |
| pubmed-article:10624433 | pubmed:dateRevised | 2009-11-3 | lld:pubmed |
| pubmed-article:10624433 | pubmed:meshHeading | pubmed-meshheading:10624433... | lld:pubmed |
| pubmed-article:10624433 | pubmed:meshHeading | pubmed-meshheading:10624433... | lld:pubmed |
| pubmed-article:10624433 | pubmed:meshHeading | pubmed-meshheading:10624433... | lld:pubmed |
| pubmed-article:10624433 | pubmed:meshHeading | pubmed-meshheading:10624433... | lld:pubmed |
| pubmed-article:10624433 | pubmed:meshHeading | pubmed-meshheading:10624433... | lld:pubmed |
| pubmed-article:10624433 | pubmed:meshHeading | pubmed-meshheading:10624433... | lld:pubmed |
| pubmed-article:10624433 | pubmed:meshHeading | pubmed-meshheading:10624433... | lld:pubmed |
| pubmed-article:10624433 | pubmed:meshHeading | pubmed-meshheading:10624433... | lld:pubmed |
| pubmed-article:10624433 | pubmed:meshHeading | pubmed-meshheading:10624433... | lld:pubmed |
| pubmed-article:10624433 | pubmed:meshHeading | pubmed-meshheading:10624433... | lld:pubmed |
| pubmed-article:10624433 | pubmed:meshHeading | pubmed-meshheading:10624433... | lld:pubmed |
| pubmed-article:10624433 | pubmed:meshHeading | pubmed-meshheading:10624433... | lld:pubmed |
| pubmed-article:10624433 | pubmed:meshHeading | pubmed-meshheading:10624433... | lld:pubmed |
| pubmed-article:10624433 | pubmed:meshHeading | pubmed-meshheading:10624433... | lld:pubmed |
| pubmed-article:10624433 | pubmed:meshHeading | pubmed-meshheading:10624433... | lld:pubmed |
| pubmed-article:10624433 | pubmed:meshHeading | pubmed-meshheading:10624433... | lld:pubmed |
| pubmed-article:10624433 | pubmed:meshHeading | pubmed-meshheading:10624433... | lld:pubmed |
| pubmed-article:10624433 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10624433 | pubmed:articleTitle | Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy. | lld:pubmed |
| pubmed-article:10624433 | pubmed:affiliation | Department of Haematology, Sheba Medical Center, Tel Hashomer, Israel. | lld:pubmed |
| pubmed-article:10624433 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10624433 | lld:pubmed |
